BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19485703)

  • 1. Growth effects of insulin and insulin analogues.
    Sandow J
    Arch Physiol Biochem; 2009 May; 115(2):72-85. PubMed ID: 19485703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferative effect of Apidra (insulin glulisine), a rapid-acting insulin analogue on mammary epithelial cells.
    Shukla A; Enzmann H; Mayer D
    Arch Physiol Biochem; 2009 Jul; 115(3):119-26. PubMed ID: 19480564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Safety of insulin analogues: what to evaluate, how to do it, and how to interpret the results].
    Hernández Mijares A; Solá Izquierdo E; García Malpartida K; Verge D
    Endocrinol Nutr; 2010 Oct; 57(8):376-80. PubMed ID: 20621572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface-expressed insulin receptors as well as IGF-I receptors both contribute to the mitogenic effects of human insulin and its analogues.
    Lundby A; Bolvig P; Hegelund AC; Hansen BF; Worm J; Lützen A; Billestrup N; Bonnesen C; Oleksiewicz MB
    J Appl Toxicol; 2015 Jul; 35(7):842-50. PubMed ID: 25413577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-responsiveness of tumor growth.
    Chantelau E
    Arch Physiol Biochem; 2009 May; 115(2):47-8. PubMed ID: 19485701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appraising the mitogenicity of insulin analogues relative to human insulin-response to: Weinstein D, Simon M, Yehezkel E, Laron Z, Werner H. Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activity in cultured cancer cells. Diabetes Metab Res Rev 2009; 25(1): 41-9.
    Kazda C; Slieker L; Ilag L; Byrd R; Rees T; Prince M
    Diabetes Metab Res Rev; 2010 Mar; 26(3):145-9. PubMed ID: 20474066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MCF-7 human mammary adenocarcinoma cells exhibit augmented responses to human insulin on a collagen IV surface.
    Listov-Saabye N; Jensen MB; Kiehr B; Hansen EW; Svendsen JE; Lundby A; Holm GM; Oleksiewicz MB
    J Appl Toxicol; 2009 Aug; 29(6):470-7. PubMed ID: 19338014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proliferative effects of insulin analogues on mammary epithelial cells.
    Mayer D; Shukla A; Enzmann H
    Arch Physiol Biochem; 2008 Feb; 114(1):38-44. PubMed ID: 18465357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin analogues with increased mitogenic potency--are they safe?
    Hansen BF
    Horm Metab Res; 2008 Jun; 40(6):431-3. PubMed ID: 18418813
    [No Abstract]   [Full Text] [Related]  

  • 10. Insulin glargine is more potent in activating the human IGF-I receptor than human insulin and insulin detemir.
    Varewijck AJ; Goudzwaard JA; Brugts MP; Lamberts SW; Hofland LJ; Janssen JA
    Growth Horm IGF Res; 2010 Dec; 20(6):427-31. PubMed ID: 21055982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IGF-1 receptor signalling determines the mitogenic potency of insulin analogues in human smooth muscle cells and fibroblasts.
    Eckardt K; May C; Koenen M; Eckel J
    Diabetologia; 2007 Dec; 50(12):2534-43. PubMed ID: 17898992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitogenic potency of insulin glargine.
    Zełobowska K; Gumprecht J; Grzeszczak W
    Endokrynol Pol; 2009; 60(1):34-9. PubMed ID: 19224503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin and its analogues and their affinities for the IGF1 receptor.
    Varewijck AJ; Janssen JA
    Endocr Relat Cancer; 2012 Oct; 19(5):F63-75. PubMed ID: 22420005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin glulisine--a comprehensive preclinical evaluation.
    Stammberger I; Seipke G; Bartels T
    Int J Toxicol; 2006; 25(1):25-33. PubMed ID: 16510354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative signaling network activation through different insulin receptor family members caused by pro-mitogenic antidiabetic insulin analogues in human mammary epithelial cells.
    ter Braak B; Wink S; Koedoot E; Pont C; Siezen C; van der Laan JW; van de Water B
    Breast Cancer Res; 2015 Jul; 17(1):97. PubMed ID: 26187749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological effects of insulin on murine melanoma cells and fish erythrophoroma cells: a comparative study.
    Luchs A; Sumida DH; Visconti MA; Castrucci AM
    Gen Comp Endocrinol; 2008 Apr; 156(2):218-23. PubMed ID: 18329644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the mitogenic potency of regular human insulin and its analogue glargine in normal and transformed human breast epithelial cells.
    Staiger K; Hennige AM; Staiger H; Häring HU; Kellerer M
    Horm Metab Res; 2007 Jan; 39(1):65-7. PubMed ID: 17226117
    [No Abstract]   [Full Text] [Related]  

  • 18. The absence of uPAR attenuates insulin-induced vascular smooth muscle cell migration and proliferation.
    Kanno Y; Kuroki A; Minamida M; Kaneiwa A; Okada K; Tomogane K; Takeuchi K; Ueshima S; Matsuo O; Matsuno H
    Thromb Res; 2008; 123(2):336-41. PubMed ID: 18579182
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of new insulin analogues HMR1964 (insulin glulisine) and HMR1423 on insulin receptors.
    Hennige AM; Strack V; Metzinger E; Seipke G; Häring HU; Kellerer M
    Diabetologia; 2005 Sep; 48(9):1891-7. PubMed ID: 16052329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human insulin A-chain peptide analog(s) with in vitro biological activity.
    Le Flem G; Pecher J; Le Flem-Bonhomme V; Withdrawn A; Rochette J; Pujol JP; Bogdanowicz P
    Cell Biochem Funct; 2009 Aug; 27(6):370-7. PubMed ID: 19618407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.